| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |